Recognition highlights Experis' breadth of services, strategic partnerships, and AI-driven technology workforce solutions MILWAUKEE , Aug. 14, 2025 /PRNewswire/ -- For the fourth year in a row, Experis® , a global leader in technology workforce solutions and part of the ManpowerGroup (NYSE: MAN) family of brands, has been named a Leader in Everest Group's U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® Assessment 2025. The report cites Experis' ability to deliver talent across application, infrastructure, data, and automation services.

Vipshop Holdings Limited (NYSE:VIPS ) Q2 2025 Earnings Call August 14, 2025 7:30 AM ET Company Participants Jessie Zheng - Head of Investor Relations Mark Wang - Chief Financial Officer Ya Shen - Co-Founder, Chairman & CEO Conference Call Participants Alicia Yap - Citigroup Inc., Research Division Chih-Hung Chang - JPMorgan Chase & Co, Research Division Wei Xiong - UBS Investment Bank, Research Division Operator Ladies and gentlemen, good day, everyone, and welcome to Vipshop Holdings Limited Second Quarter 2025 Earnings Conference Call. At this time, I would like to turn the call over to Ms.

Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments Underway SmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead in Scent Intelligence. Debuting at Automation Taipei 2025 in Partnership with Kenmec and ugo SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today launched its first commercial AI Nose module optimized for industrial and healthcare settings, marking a pivotal milestone in the global commercialization of AI-powered digital olfaction.

HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions, today announced the dual listing of its common stock on NYSE Texas, the fully electronic equities exchange headquartered in Dallas. Insperity will maintain its primary listing on the New York Stock Exchange and trade with the same “NSP” ticker symbol on NYSE Texas. “We're proud to be a Founding Member of this innovative new platform in Texas, the state where Insperity.

ESTERO, Fla.--(BUSINESS WIRE)--Hertz Car Sales today announced the nationwide expansion of its popular Hertz Rent2Buy® program to more than 100 cities. As consumers increasingly embrace the “try before you buy” approach—from furniture to fashion—Hertz Car Sales is meeting the moment by redefining the traditional test drive. The Rent2Buy program offers thousands of well-maintained, competitively priced used vehicles—including newly added 2025 models—for an extended test drive. Rent2Buy eliminate.

LONDON & SAN JOSE, Calif.--(BUSINESS WIRE)---- $CALX #calix--Calix, Inc. (NYSE: CALX) today announced the appointment of Amritesh (Amrit) Chaudhuri as executive vice president and chief marketing officer. With more than 20 years of leadership spanning marketing, product, sales, and revenue operations—and over a decade of applying AI to cloud and customer experience (CX) transformation—Amrit joins as chief marketing officer to lead the entire Calix go-to-market organization, including corporate, product, field,.

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Heather H. Hunter - Senior VP & Chief Corporate Affairs Officer Jesse Neri - Senior VP & CFO Mark Strobeck - President, CEO & Director Conference Call Participants Jeremy Pearlman - Maxim Group LLC, Research Division Raghuram Selvaraju - H.C.

LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or "the Company") (NASDAQ: PRAX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the U.S. government amid a protracted legal dispute over the technology, it said on Thursday.

ZTO eyes strong parcel volume growth for Q2 despite freight forwarding weakness and trade woes.

LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Albany International Corp. ("Albany" or "the Company") (NYSE: AIN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Q2: Revenue of $7.14 Million; Net Income of $1.1 Million; non-GAAP EPS of $0.49 ; EBITDA of $2.5 Million H1: Revenue of $14.2 Million; Gross Margin of 61.2%; Non-GAAP Net Income of $7.4 Million TEL AVIV, Israel , Aug. 14, 2025 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, today reported results for the second quarter, ended June 30, 2025. First Half Ended June 30, 2025, Financial Highlights (Compared to the First Half of 2024) Revenue was $14.2 million, compared to $14.4 million.

Bullish had a highly successful IPO, raising $1.1B which signaled strong investor appetite for crypto assets. The platform offers a comprehensive suite of crypto trading and data services, competing with companies like Binance, Coinbase and Robinhood. Bullish's profitability is tied to crypto market volatility. The firm lost money in Q1'25, but was profitable in the previous two fiscal years.

Rate cut optimism is fueling U.S. markets, with DIS, CCL, HAS, NFLX and RL set for potential gains in consumer discretionary.

LOS ANGELES , Aug. 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against KinderCare Learning Companies, Inc. ("KinderCare" or "the Company") (NYSE: KLC) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted in October 2024, are encouraged to contact the firm before October 14, 2025.

FET has a promising strategy that focuses on niche segments. This way, they've gained momentum in 2026 despite rig declines. Q2's revenue came in at the top of their guidance, with an impressive subsea backlog that should give them long-term revenue stability. Their coiled tubing segment also gained in the US and the Middle East, while international sales expanded.

Kelowna, British Columbia – TheNewswire - August 14, 2025 – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “ Company ” or “ Lexaria ”), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization (“ CRO ”) has completed the important study milestone known as last patent last visit (“ LPLV ”) in Lexaria's Phase 1b glucagon-like peptide-1 (“ GLP-1 ”) study in Australia, GLP-1-H24-4 (the “ Study ”). “We are delighted that this important milestone has been achieved on schedule, concluding all patient dosing and clinical testing in our Study,” said John Docherty, …

Brinker International Inc. NYSE: EAT stock is surging over 2.5% on strong volume after the company's strong second-quarter earnings report. The company reported strong, 21.3% same-store sales growth for its Chili's and Maggiano's chains.

KELOWNA, BC / ACCESS Newswire / August 14, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization ("CRO") has completed the important study milestone known as last patent last visit ("LPLV") in Lexaria's Phase 1b glucagon-like peptide-1 ("GLP-1") study in Australia, GLP-1-H24-4 (the "Study"). "We are delighted that this important milestone has been achieved on schedule, concluding all patient dosing and clinical testing in our Study," said John Docherty, Lexaria's President and CSO.

BigBear.ai Holdings, Inc.'s Q2 '25 results show declining revenue, shrinking margins, and ballooning losses, despite management's optimism and strong cash reserves. The current $5.81 share price reflects speculation, not fundamentals; the stock's 350% rally lacks support from real business progress or profitability. For an upgrade, I need to see reduced cash burn, meaningful new contracts, and tangible revenue from international partnerships in Q3.